![\"Laser](\"https:\/\/fotonmedix.com\/wp-content\/uploads\/2026\/08\/laser-therapy-for-dogs5.jpg\")
<\/figure>\n\n\n\nWhy 1470 nm Is Different<\/p>\n\n\n\n
1470 nm is a very different tool.<\/p>\n\n\n\n
Water absorption rises dramatically in this region. Published data comparing near-infrared wavelengths show that water absorption at 1470 nm is many times higher than at 980 nm, which produces much more localized energy deposition. (J-STAGE)<\/p>\n\n\n\n
This property is highly useful in laser surgery, where controlled tissue vaporization or coagulation is required.<\/p>\n\n\n\n
It is not automatically a reason to use 1470 nm for routine non-invasive canine arthritis treatment.<\/p>\n\n\n\n
This distinction is important for medical distributors and veterinary clinics evaluating a high-intensity laser platform.<\/p>\n\n\n\n
One machine can contain multiple wavelength channels, but that does not mean every channel should be used at maximum output for every indication.<\/p>\n\n\n\n
A good veterinary system should give the clinician control over the treatment strategy rather than forcing one wavelength and one power profile onto every patient.<\/p>\n\n\n\n
Duty Cycle Is the Safety Valve Between Power and Heat<\/p>\n\n\n\n
The most practical concept in high-intensity laser therapy is often not maximum power.<\/p>\n\n\n\n
It is average energy delivery over time.<\/p>\n\n\n\n
Suppose a clinician uses a high peak output but does not deliver that output continuously. During the \u201con\u201d period, tissue receives a strong optical stimulus. During the \u201coff\u201d period, thermal diffusion and blood perfusion have time to redistribute energy.<\/p>\n\n\n\n
This is where duty cycle becomes clinically relevant.<\/p>\n\n\n\n
A 50% duty cycle means the laser is active for approximately half of the pulse cycle. A lower duty cycle reduces average power while maintaining a higher instantaneous peak during the active portion.<\/p>\n\n\n\n
The distinction is important because peak power and average power describe different physical behaviors.<\/p>\n\n\n\n
Recent experimental work on dual-wavelength laser-tissue interaction has also investigated pulsed operation using a 100 ms pulse, 50% duty cycle, and 5 Hz frequency, demonstrating that pulse structure is an important parameter when controlling laser-tissue effects. (Life Science Network)<\/p>\n\n\n\n
For veterinary rehabilitation, the practical lesson is straightforward:<\/p>\n\n\n\n
If the target requires strong energy delivery but the surface begins to become uncomfortable, changing the temporal structure may be more useful than simply abandoning high-intensity treatment.<\/p>\n\n\n\n
The handpiece should also remain in controlled motion rather than sitting over one small point for too long.<\/p>\n\n\n\n
A Simulated Canine Arthritis Case From a Veterinary Rehabilitation Department<\/p>\n\n\n\n
The following case is a simulated clinical training case, created to demonstrate how a veterinary rehabilitation team could reason through wavelength selection, power, pulse structure, energy, and treatment progression. It is not presented as a published patient record and should not be treated as a universal treatment prescription.<\/p>\n\n\n\n
\u0418\u0434\u0435\u043d\u0442\u0438\u0444\u0438\u043a\u0430\u0446\u0438\u044f \u0434\u0435\u043b\u0430<\/p>\n\n\n\n
The patient is a 9-year-old male neutered Labrador Retriever weighing 34.2 kg.<\/p>\n\n\n\n
Radiographic evaluation shows bilateral stifle osteoarthritis, with the right side clinically dominant.<\/p>\n\n\n\n
The right stifle is graded as moderate-to-severe degenerative joint disease, corresponding approximately to a modified radiographic grade 3 of 4 used within the training protocol.<\/p>\n\n\n\n
The dog has difficulty rising after rest, reduced willingness to climb stairs, shortened right hind-limb stride, and discomfort during extension.<\/p>\n\n\n\n
The owner reports that conventional analgesic management improves comfort but does not restore normal activity.<\/p>\n\n\n\n
The rehabilitation objective is not to \u201cerase arthritis.\u201d<\/p>\n\n\n\n
The objective is to reduce pain-related movement restriction, improve functional activity, and support a broader multimodal rehabilitation program.<\/p>\n\n\n\n
Simulated Clinical Case Table<\/p>\n\n\n\n
ParameterSimulated Case DetailDepartmentVeterinary Rehabilitation and Physical MedicineCase NumberVR-HILT-2026-027PatientLabrador RetrieverAge9 yearsSexMale, neuteredBody Weight34.2 kgPrimary DiagnosisCanine stifle osteoarthritisClinical GradeModerate-to-severe, modified radiographic Grade 3\/4Dominant SideRight stifleBaseline Functional IssueSlow rising, stair avoidance, shortened stridePrimary Treatment ObjectivePain modulation and functional mobility supportLaser PlatformHigh-intensity veterinary Class IV laserPrimary Wavelength Strategy810 nm + 915 nm + 940 nm + 980 nmSimulated Wavelength Allocation810 nm 30%, 915 nm 25%, 940 nm 20%, 980 nm 25%Peak PowerUp to 30 W during pulsed deliveryInitial Average PowerApproximately 12 WPulse Frequency10 HzInitial Duty Cycle40%Initial Session Energy720 JTreatment AreaRight stifle and surrounding periarticular soft tissueTreatment Frequency2 sessions per week initiallyPlanned Initial Course3 weeksReassessmentEnd of Week 1, Week 3, Week 6Thermal MonitoringContinuous patient response and surface temperature observationAdditional RehabilitationControlled exercise and range-of-motion work<\/p>\n\n\n\n
The wavelength allocation above is a simulated protocol model, not a manufacturer-prescribed treatment setting.<\/p>\n\n\n\n
The reason for including 810 nm is to maintain a relatively favorable near-infrared penetration profile. A review of PBM optical behavior identifies the region around 800 nm as being close to a favorable penetration window because scattering is comparatively reduced. (PubMed Central (PMC))<\/p>\n\n\n\n
The 915 and 940 nm components broaden the optical interaction across the treatment volume, while the 980 nm component adds a stronger thermal interaction that must be controlled by movement, exposure time, pulse structure, and patient feedback.<\/p>\n\n\n\n
\u0421\u0435\u0441\u0441\u0438\u044f 1<\/p>\n\n\n\n
The dog initially resists full stifle extension.<\/p>\n\n\n\n
The operator begins with a lower average output rather than immediately using maximum available power.<\/p>\n\n\n\n
The handpiece is maintained in contact or near-contact with the treatment area and moved continuously across the periarticular tissues.<\/p>\n\n\n\n
The total delivered energy is 720 J.<\/p>\n\n\n\n
The dog shows mild warmth but no withdrawal response.<\/p>\n\n\n\n
The clinician records:<\/p>\n\n\n\n
Stifle extension tolerance improved immediately after treatment<\/p>\n\n\n\n
No visible erythema<\/p>\n\n\n\n
No signs of excessive discomfort<\/p>\n\n\n\n
Gait remains mildly shortened<\/p>\n\n\n\n
Owner reports no immediate adverse response<\/p>\n\n\n\n
The important observation is not that the dog suddenly becomes \u201ccured.\u201d<\/p>\n\n\n\n
It is that the treatment can be delivered at a clinically meaningful energy level without creating unacceptable surface heating.<\/p>\n\n\n\n
End of Week 1<\/p>\n\n\n\n
After two sessions, the simulated owner-reported pain interference score falls from 7\/10 to 5\/10.<\/p>\n\n\n\n
The dog begins standing more quickly after lying down.<\/p>\n\n\n\n
The right hind limb is still visibly weaker, but the dog voluntarily walks farther before slowing.<\/p>\n\n\n\n
The treatment energy is increased to approximately 850 J per session, while the clinician keeps the duty cycle below continuous output.<\/p>\n\n\n\n
The purpose of the adjustment is not simply to increase total joules.<\/p>\n\n\n\n
It is to increase the useful dose while maintaining thermal tolerance.<\/p>\n\n\n\n
\u041d\u0435\u0434\u0435\u043b\u044f 2<\/p>\n\n\n\n
The dog receives two further sessions.<\/p>\n\n\n\n
The clinician changes the treatment pattern slightly.<\/p>\n\n\n\n
The central stifle region receives shorter exposure periods, while the surrounding quadriceps, hamstring, periarticular, and soft-tissue regions receive broader scanning.<\/p>\n\n\n\n
This is a critical practical detail.<\/p>\n\n\n\n
An arthritic joint is not just a piece of cartilage.<\/p>\n\n\n\n
Pain-related movement changes can create secondary muscle tension and altered loading patterns. Treating only the anatomical center of the joint can therefore miss part of the functional problem.<\/p>\n\n\n\n
The simulated treatment energy is maintained around 850\u2013900 J per session.<\/p>\n\n\n\n
Week 3 Reassessment<\/p>\n\n\n\n
At the end of six treatment sessions, the simulated functional results are:<\/p>\n\n\n\n
Clinical MeasureBaselineWeek 1Week 3Pain interference score7\/105\/103\/10Rising from restMarkedly slowModerate difficultyMild difficultyStair toleranceAvoids stairs3\u20134 steps8\u201310 stepsRight hind-limb strideClearly shortenedMildly shortenedNear-symmetrical at slow walkingPassive extension tolerancePoorImprovedClearly improvedOwner-rated daily activity4\/106\/108\/10Simulated treatment energy\/session720 J850 J900 J<\/p>\n\n\n\n
These values are deliberately presented as simulated training data.<\/p>\n\n\n\n
They should not be interpreted as expected outcomes for every dog.<\/p>\n\n\n\n
Why the Treatment Was Not Simply Set to Maximum Power<\/p>\n\n\n\n
This is where high-intensity treatment differs from a \u201cturn it up\u201d approach.<\/p>\n\n\n\n
VetMedix-Max is specified for up to 38 W peak power and provides super-pulse operation, adjustable thermal sensation, and multiple wavelengths. (FotonMedix |)<\/p>\n\n\n\n
A 38 W peak capability does not mean that every canine joint should receive 38 W continuously.<\/p>\n\n\n\n
The clinical system needs headroom.<\/p>\n\n\n\n
The operator can use higher peak output during short pulse intervals while reducing the average thermal burden through duty-cycle control and scanning.<\/p>\n\n\n\n
This creates a more useful relationship between intensity and treatment comfort.<\/p>\n\n\n\n
The objective becomes:<\/p>\n\n\n\n
strong optical stimulation without allowing superficial temperature to become the limiting factor.<\/p>\n\n\n\n
What the Published Canine Evidence Actually Shows<\/p>\n\n\n\n
It is important not to overstate the veterinary evidence.<\/p>\n\n\n\n
A 2022 randomized double-blinded controlled trial evaluated Class IV photobiomodulation in 20 dogs and 40 joints with osteoarthritis. The treatment group received Class IV laser therapy over three weeks. The investigators reported better outcomes in several pain, function, gait, and osteoarthritis-related measures at selected follow-up points, particularly at days 8, 15, and 30. (PubMed)<\/p>\n\n\n\n
That is useful evidence, but it does not mean every dog will respond identically.<\/p>\n\n\n\n
Another study involving 23 dogs with naturally occurring osteoarthritis used six consecutive weekly laser treatments and objective accelerometer monitoring. Daily activity and step counts increased from baseline during the treatment period, and systemic analgesics were reduced in 50% of the dogs during the study. (PubMed Central (PMC))<\/p>\n\n\n\n
A separate retrospective study of 17 dogs reported reductions in pain scores after laser treatment and found that analgesic therapy was reduced by the clinician at week 2 in 13 dogs. No laser-related side effects were observed in that cohort. (PubMed)<\/p>\n\n\n\n
The evidence therefore supports laser therapy as a potentially useful component of multimodal canine osteoarthritis management.<\/p>\n\n\n\n
It does not justify claiming that laser therapy replaces medication, surgery, weight management, exercise therapy, or orthopedic intervention.<\/p>\n\n\n\n
Where Dog Laser Therapy Fits in a Real Clinic<\/p>\n\n\n\n
A practical dog laser therapy workflow is usually more valuable when the clinician thinks in terms of functional rehabilitation rather than isolated energy delivery.<\/p>\n\n\n\n
For example, a dog with hip osteoarthritis may receive:<\/p>\n\n\n\n
Orthopedic assessment<\/p>\n\n\n\n
Pain scoring<\/p>\n\n\n\n
Weight and activity review<\/p>\n\n\n\n
\u041b\u0430\u0437\u0435\u0440\u043d\u043e\u0435 \u043b\u0435\u0447\u0435\u043d\u0438\u0435<\/p>\n\n\n\n
Passive range-of-motion work<\/p>\n\n\n\n
Controlled walking<\/p>\n\n\n\n
\u0423\u043a\u0440\u0435\u043f\u043b\u044f\u044e\u0449\u0438\u0435 \u0443\u043f\u0440\u0430\u0436\u043d\u0435\u043d\u0438\u044f<\/p>\n\n\n\n
Reassessment of gait and owner-reported function<\/p>\n\n\n\n
The laser becomes one component of a broader rehabilitation plan.<\/p>\n\n\n\n
This matters because pain reduction can create an opportunity for movement.<\/p>\n\n\n\n
Movement can then support muscle preservation.<\/p>\n\n\n\n
Muscle preservation can reduce abnormal joint loading.<\/p>\n\n\n\n
The result is a more useful clinical chain than simply recording the number of joules delivered.<\/p>\n\n\n\n
Why Laser Therapy for Dogs Arthritis Should Be Treated as a Dosimetry Problem<\/p>\n\n\n\n
The search phrase laser therapy for dogs arthritis sounds simple.<\/p>\n\n\n\n
The clinical reality is not.<\/p>\n\n\n\n
Arthritis can involve cartilage degeneration, synovial inflammation, capsular thickening, osteophyte formation, periarticular muscle changes, altered gait, and chronic pain sensitization.<\/p>\n\n\n\n
These tissues do not have identical optical properties.<\/p>\n\n\n\n
A superficial synovial or periarticular target may respond differently from a deep joint structure surrounded by thick muscle.<\/p>\n\n\n\n
That is why a fixed \u201cone protocol for all dogs\u201d approach is difficult to defend scientifically.<\/p>\n\n\n\n
The clinician needs to consider:<\/p>\n\n\n\n
Tissue Depth<\/p>\n\n\n\n
A deep hip joint requires more attention to photon attenuation and treatment geometry than a superficial digital joint.<\/p>\n\n\n\n
\u0414\u043b\u0438\u043d\u0430 \u0432\u043e\u043b\u043d\u044b<\/p>\n\n\n\n
Longer wavelengths generally scatter less, but absorption can increase sharply depending on the wavelength and tissue chromophore.<\/p>\n\n\n\n
\u041c\u043e\u0449\u043d\u043e\u0441\u0442\u044c<\/p>\n\n\n\n
Higher peak power can improve treatment efficiency but also increases the need for thermal management.<\/p>\n\n\n\n
\u0427\u0430\u0441\u0442\u043e\u0442\u0430 \u0438\u043c\u043f\u0443\u043b\u044c\u0441\u043e\u0432<\/p>\n\n\n\n
Pulse frequency affects how energy is distributed over time and can be used with duty cycle to modify average exposure.<\/p>\n\n\n\n
\u0426\u0438\u043a\u043b \u0440\u0430\u0431\u043e\u0442\u044b<\/p>\n\n\n\n
Lowering duty cycle can reduce average thermal load while preserving higher instantaneous output.<\/p>\n\n\n\n
Contact Technique<\/p>\n\n\n\n
Poor contact or inconsistent handpiece movement changes the delivered optical dose and makes treatment reproducibility worse.<\/p>\n\n\n\n
\u041e\u0431\u0449\u0430\u044f \u044d\u043d\u0435\u0440\u0433\u0438\u044f<\/p>\n\n\n\n
Joules matter, but total joules without treatment area, time, power profile, and wavelength information are incomplete.<\/p>\n\n\n\n
This is why professional laser protocols should record more than \u201c900 J delivered.\u201d<\/p>\n\n\n\n
A B2B View of the Veterinary Laser Investment<\/p>\n\n\n\n
For a veterinary hospital or rehabilitation center, the business question is also practical.<\/p>\n\n\n\n
A machine dedicated to one narrow indication can be difficult to justify.<\/p>\n\n\n\n
A multi-wavelength veterinary platform can support orthopedic rehabilitation, pain management, inflammation control, wound management, and selected surgical applications depending on configuration and local regulatory scope.<\/p>\n\n\n\n
FotonMedix positions VetMedix-Max as a medical-grade veterinary platform combining laser therapy and laser surgery, with five wavelengths, 38 W peak power, super-pulse operation, thermal adjustment, and a stated 15 cm tissue penetration capability. (FotonMedix |)<\/p>\n\n\n\n
The broader FotonMedix LaserMedix platform also emphasizes five-wavelength treatment, high-energy PBM, depth-maintaining technology, dual hot-and-cold functionality, and temperature indication. (FotonMedix |)<\/p>\n\n\n\n
For a distributor, this creates a clearer sales proposition than simply saying \u201chigh-power laser.\u201d<\/p>\n\n\n\n
The conversation can move toward clinical workflow:<\/p>\n\n\n\n
Can the same platform support chronic pain cases?<\/p>\n\n\n\n
Can it support canine arthritis rehabilitation?<\/p>\n\n\n\n
Can clinicians adjust treatment depth and thermal sensation?<\/p>\n\n\n\n
Can the veterinary team establish repeatable protocols?<\/p>\n\n\n\n
Can the system be integrated into rehabilitation rather than used as an isolated procedure?<\/p>\n\n\n\n
Those are questions a clinic manager can actually answer.<\/p>\n\n\n\n
The Difference Owners Notice Is Usually Not the Laser<\/p>\n\n\n\n
The owner does not care whether the machine delivered 720 J or 900 J.<\/p>\n\n\n\n
They care whether the dog gets up without struggling.<\/p>\n\n\n\n
They care whether the dog wants to walk to the door.<\/p>\n\n\n\n
They care whether stairs become possible again.<\/p>\n\n\n\n
They care whether the dog can sleep comfortably.<\/p>\n\n\n\n
That is the real endpoint.<\/p>\n\n\n\n
Published canine osteoarthritis research has increasingly used functional outcomes rather than relying only on imaging. In the 23-dog accelerometer study, objective activity measurements increased during the treatment course, showing why mobility can be a more meaningful real-world endpoint than simply describing an X-ray. (PubMed Central (PMC))<\/p>\n\n\n\n
Radiographic arthritis may remain.<\/p>\n\n\n\n
The osteophytes may remain.<\/p>\n\n\n\n
The degenerative changes may remain.<\/p>\n\n\n\n
But if pain is better controlled and the dog moves more normally, the rehabilitation outcome can still be clinically meaningful.<\/p>\n\n\n\n
Laser Versus Traditional Care Is Not Really an Either-Or Decision<\/p>\n\n\n\n
It is tempting to frame laser treatment against medication as if one must replace the other.<\/p>\n\n\n\n
Clinical practice is more complicated.<\/p>\n\n\n\n
NSAIDs can be highly effective for canine osteoarthritis, but long-term pharmacological management requires appropriate veterinary assessment and monitoring.<\/p>\n\n\n\n
Exercise therapy addresses strength and function.<\/p>\n\n\n\n
Weight management reduces mechanical loading.<\/p>\n\n\n\n
Joint injections may be appropriate for selected cases.<\/p>\n\n\n\n
Surgery can be necessary when structural disease is severe.<\/p>\n\n\n\n
Laser therapy offers another non-invasive modality that can be incorporated into this broader plan.<\/p>\n\n\n\n
A 2026 evidence review concluded that the available evidence for adding laser therapy to NSAID treatment remains limited and described the strength of evidence as weak, while still suggesting possible improvements in pain and lameness. (PubMed)<\/p>\n\n\n\n
That is exactly the kind of statement that should appear in serious B2B medical marketing.<\/p>\n\n\n\n
The product should be sold on controllable technology and clinical utility, not on exaggerated promises.<\/p>\n\n\n\n
Practical Takeaway for Veterinary Teams<\/p>\n\n\n\n
For a large dog with deep joint pain, the hardest part is not producing more laser energy.<\/p>\n\n\n\n
The hard part is delivering enough useful energy to the target while keeping the superficial tissues comfortable.<\/p>\n\n\n\n
That requires an understanding of optical attenuation, wavelength-dependent absorption, treatment geometry, power, pulse frequency, duty cycle, exposure time, and tissue temperature.<\/p>\n\n\n\n
980 nm can create meaningful thermal interaction because tissue water absorbs part of the energy.<\/p>\n\n\n\n
1470 nm interacts with water much more strongly and is therefore far more localized and thermally intense, making it particularly relevant to surgical tissue applications rather than automatically suitable for non-invasive arthritis protocols. (PubMed Central (PMC))<\/p>\n\n\n\n
Near the 800 nm region, tissue scattering is comparatively favorable for penetration, which helps explain why multi-wavelength systems can be useful when treatment depth varies between anatomical targets. (PubMed Central (PMC))<\/p>\n\n\n\n
Pulse structure then gives the clinician another control layer.<\/p>\n\n\n\n
Instead of treating peak power as the whole story, the clinician can manage average exposure and thermal accumulation through duty cycle, frequency, handpiece movement, and treatment duration.<\/p>\n\n\n\n
That is the real advantage of modern high-intensity Class IV systems.<\/p>\n\n\n\n
Not simply more power.<\/p>\n\n\n\n
More controllable power.<\/p>\n\n\n\n
For laser therapy for dogs, that difference becomes particularly important when the target is deep, the patient is large, and the treatment needs to be repeated over several weeks.<\/p>\n\n\n\n
For dog laser therapy, the most useful platform is not necessarily the machine with the biggest number on the specification sheet. It is the system that allows the veterinary team to adjust wavelength, intensity, pulse behavior, treatment time, and thermal response according to the patient.<\/p>\n\n\n\n
And for laser therapy for dogs arthritis, the clinical goal should remain grounded in the dog\u2019s actual life: less pain during movement, better functional activity, improved tolerance of rehabilitation, and a treatment process that can be integrated with the rest of veterinary care.<\/p>\n\n\n\n
That is where high-intensity laser therapy can earn its place beside conventional treatment rather than being marketed as a replacement for it.<\/p>","protected":false},"excerpt":{"rendered":"
High-energy penetration, wavelength-selective absorption, pulse thermal control An older dog can walk into a veterinary rehabilitation room looking fine and still refuse to climb three steps. The owner usually describes the same frustrating pattern: the dog gets up slowly, walks better for a few minutes, then starts shortening the stride again. Oral medication may reduce […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"themepark_post_bcolor":"#f5f5f5","themepark_post_width":"1022px","themepark_post_img":"","themepark_post_img_po":"left","themepark_post_img_re":false,"themepark_post_img_cover":false,"themepark_post_img_fixed":false,"themepark_post_hide_title":false,"themepark_post_main_b":"","themepark_post_main_p":100,"themepark_paddingblock":false,"slim_seo":{"title":"\u0414\u043b\u044f \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u0441\u0438\u043b\u044c\u043d\u043e\u0439 \u0431\u043e\u043b\u0438 \u0432 \u0441\u0443\u0441\u0442\u0430\u0432\u0430\u0445 \u0442\u0440\u0435\u0431\u0443\u0435\u0442\u0441\u044f \u043c\u043e\u0449\u043d\u043e\u0441\u0442\u044c \u0431\u0435\u0437 \u0442\u0435\u043f\u043b\u043e\u0432\u043e\u0439 \u043f\u0435\u0440\u0435\u0433\u0440\u0443\u0437\u043a\u0438","description":"High-intensity Class IV laser case analysis for canine arthritis using wavelength selection, tissue absorption, pulse control and thermal management."},"_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[19],"tags":[868,844,835,839],"class_list":["post-17288","post","type-post","status-publish","format-standard","hentry","category-industry-news","tag-dog-laser","tag-dog-laser-therapy","tag-iv-laser-therapy","tag-laser-surgery"],"metadata":{"_edit_lock":["1787627801:1"],"wpil_sync_report3":["1"],"wpil_links_inbound_internal_count":["0"],"wpil_links_inbound_internal_count_data":["eJxLtDKwqq4FAAZPAf4="],"wpil_links_outbound_internal_count":["0"],"wpil_links_outbound_internal_count_data":["eJxLtDKwqq4FAAZPAf4="],"wpil_links_outbound_external_count":["0"],"wpil_links_outbound_external_count_data":["eJxLtDKwqq4FAAZPAf4="],"wpil_sync_report2_time":["2026-08-25T03:16:08+00:00"],"_edit_last":["1"],"_aioseo_title":[null],"_aioseo_description":[null],"_aioseo_og_title":[""],"_aioseo_og_description":[""],"_aioseo_og_article_section":[""],"_aioseo_twitter_title":[""],"_aioseo_twitter_description":[""],"_aioseo_keywords":["a:0:{}"],"_aioseo_og_article_tags":["a:0:{}"],"catce":["sidebar-widgets4"],"slim_seo":["a:2:{s:5:\"title\";s:52:\"Deep Joint Pain Needs Power Without Thermal Overload\";s:11:\"description\";s:149:\"High-intensity Class IV laser case analysis for canine arthritis using wavelength selection, tissue absorption, pulse control and thermal management.\";}"],"views":["10"]},"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t